Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614040 · ClinicalTrials.gov registry record · NA
Saline Against Lactated Ringers or Plasmalyte in the Emergency Department
A NA study of Critical Illness and Acute Kidney Injury, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 14,000
- Enrollment target
- 1
- Study location
NCT02614040: Completed NA study of Critical Illness and Acute Kidney Injury, sponsored by Vanderbilt University.
NCT02614040 is a NA study of Critical Illness and Acute Kidney Injury that has completed, run by Vanderbilt University. The registered enrollment target is 14,000 participants, above the 2,985-participant average among 91 other Critical Illness trials with a reported enrollment target (369% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02614040, a NA study of Critical Illness and Acute Kidney Injury, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a cluster-randomized, single-center trial comparing 0.9% saline (normal saline) vs physiologically-balanced crystalloid fluids (Lactated Ringers or Plasmalyte A) for intravenous fluid administration in the emergency department.
Primary Outcome
The number of days alive and free of hospitalization in the first 28 days after study enrollment. Patients alive at the time of discharge will be presumed to be alive at 28 days. A patient who dies before hospital discharge will receive zero hospital-free days. A patient who remains in the hospital 28 days after enrollment will receive zero hospital-free days.
Conditions Studied
Interventions
- OTHER 0.9% Saline
- OTHER Physiologically-balanced isotonic crystalloid
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center Adult Emergency Department - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,000 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2017-06-30 |
| Phase | NA |
What the finished NCT02614040 record still lists
NCT02614040 is an interventional study that assigns participants to a tested intervention. Its 14,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,985-participant average among 91 other Critical Illness trials with a reported enrollment target (369% higher).
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which 0.9% Saline is the first listed.
NCT02614040 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02614040 about?
NCT02614040 is a clinical study titled "Saline Against Lactated Ringers or Plasmalyte in the Emergency Department". This study will be a cluster-randomized, single-center trial comparing 0.9% saline (normal saline) vs physiologically-balanced crystalloid fluids (Lactated Ringers or Plasmalyte A) for intravenous fluid administration in the emergency department.
What is the current status of trial NCT02614040?
This trial is currently completed. It is a NA study. The enrollment target is 14,000 participants. The study started on 2016-01-01. Estimated completion is 2017-06-30.
What conditions does trial NCT02614040 study?
This clinical trial studies the following conditions: Critical Illness, Acute Kidney Injury.
What interventions are being tested in trial NCT02614040?
The interventions under investigation include: 0.9% Saline (OTHER), Physiologically-balanced isotonic crystalloid (OTHER).
Who is sponsoring clinical trial NCT02614040?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02614040 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02614040's enrollment target sits among peer trials
14,000 2nd of 91 the highest of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
PUSH-IT Continuing Enteral Feeds for Tracheostomy
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI